Dilated cardiomyopathy as a presenting feature of Cushing's syndrome

Intern Med. 2013;52(10):1067-71. doi: 10.2169/internalmedicine.52.9051. Epub 2013 May 15.

Abstract

Cardiovascular complications, including cardiomegaly, myocardial ischemia and left ventricular hypertrophy, are some of the major determinants of the mortality rate in patients with Cushing's syndrome. We herein report the case of a patient with Cushing's syndrome caused by an adrenal adenoma who presented with congestive heart failure secondary to dilated cardiomyopathy. Follow-up echocardiography showed a marked improvement in the left ventricular cardiac function, and the plasma B-type natriuretic peptide (BNP) levels regressed after successful treatment. "Reversible" dilated cardiomyopathy is rarely associated with Cushing's syndrome; however, it should be recognized. Administering appropriate treatment in a timely manner can reverse this cardiomyopathy along with the other symptoms of Cushing's syndrome.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adenoma / complications*
  • Adenoma / surgery
  • Adrenal Cortex Neoplasms / complications*
  • Adrenal Cortex Neoplasms / surgery
  • Adrenalectomy
  • Aged
  • Biomarkers
  • Cardiomyopathy, Dilated / blood
  • Cardiomyopathy, Dilated / etiology*
  • Cardiovascular Agents / therapeutic use
  • Circadian Rhythm
  • Cushing Syndrome / complications*
  • Cushing Syndrome / diagnosis
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / etiology
  • Female
  • Glycated Hemoglobin / analysis
  • Heart Failure / blood
  • Heart Failure / drug therapy
  • Heart Failure / etiology*
  • Humans
  • Hydrocortisone / blood
  • Hydrocortisone / urine
  • Natriuretic Peptide, Brain / blood
  • Remission Induction

Substances

  • Biomarkers
  • Cardiovascular Agents
  • Glycated Hemoglobin A
  • Natriuretic Peptide, Brain
  • Hydrocortisone